Pharma

Dren Bio Partners with Novartis to Discover and Develop Novel Targeted Myeloid Engagers for Cancer

Dren Bio Partners with Novartis to Discover and Develop Novel Targeted Myeloid Engagers for Cancer

Shots: Novartis and Dren Bio have signed a strategic collaboration to discover and...

Ipsen Collaborates with Day One Biopharmaceuticals for the commercialization of Tovorafenib to Treat Pediatric Low-Grade Glioma

Ipsen Collaborates with Day One Biopharmaceuticals for the commercialization of Tovorafenib to Treat Pediatric Low-Grade Glioma

Shots: Ipsen and Day One Biopharmaceuticals have entered into an exclusive ex-US l...

Triastek Partners with BioNTech to Develop 3D Printed Oral RNA Therapeutics

Triastek Partners with BioNTech to Develop 3D Printed Oral RNA Therapeutics

Shots: Triastek and BioNTech have entered into a research collaboration and platfo...

Pinetree Therapeutics Collaborates with AstraZeneca to Develop its Preclinical Candidate

Pinetree Therapeutics Collaborates with AstraZeneca to Develop its Preclinical Candidate

Shots: Pinetree Therapeutics has signed an exclusive agreement with AstraZeneca to...

Aligos Therapeutics Partners with Xiamen Amoytop Biotech for the Development of ALG-000184

Aligos Therapeutics Partners with Xiamen Amoytop Biotech for the Development of ALG-000184

Shots: Aligos Therapeutics has signed a clinical trial collaboration agreement wit...

Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio

Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio

Shots: Meitheal has entered into an asset purchase agreement with Nabriva to acqui...

Image